“…The halopyrimidine 5‐bromo‐2′‐deoxyuridine (BrdU) is a chemically synthesized bromine‐tagged base analogue that is incorporated instead of thymidine into newly synthesized DNA during the S‐phase of the cell cycle (Lehner et al, 2011). Since the introduction of monoclonal antibodies against BrdU (Gratzner, 1982), an increasing number of methodologies have been used for the immunodetection of this nucleoside in the replicating DNA (Molina, Rodríguez‐Vázquez, Owen, Valero, & Martí, 2017). One of the advantages of the use of BrdU is that it has allowed to microscopically analyze the developmental timetables, fate and survival of different neuron types in the central nervous system (Lanctot et al, 2017; Martí, Santa‐Cruz, Serra, & Hervás, 2015; Martí, Santa‐Cruz, Serra, & Hervás, 2016; Taupin, 2007).…”